Large-scale testing (Phase 3)Study completedNCT02135692
What this trial is testing
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
Who this might be right for
Asthma
GlaxoSmithKline 339
Showing 20 of 186 results